MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-10-0037686
Riocure Pharmaceuticals Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.34 Cr
▲ 2% YoY
Net profit · FY 2024
₹1.89 Lakh
Net margin 1.4%
EBITDA · FY 2024
₹2.74 Lakh
EBITDA margin 2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹35.43 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Riocure Pharmaceuticals Private Limited
Data last updated:
Riocure Pharmaceuticals Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24297AP2018PTC109498. Its GSTIN is 37AAJCR1997B1Z5 (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rajesh Kumar Patra and Sujata Pradhan Subhadarsini.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No.5 – 65 Vivekananda Nagar Old Dairy Farm Arilova, Visakhapatnam, Andhra Pradesh, India – 530040.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.34 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.89 Lakh (net margin 1.4%) and EBITDA of ₹2.74 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 21% over five years.
The company is associated with 1 brand: Riocure Pharmaceuticals. As per MCA filings, the company has open charges of ₹35.43 Lakh on record.
Riocure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0037686). For more details, the company can be reached via its website riocurepharma.com.
Company details
CIN U24297AP2018PTC109498
Registration Number 109498
Incorporation Date 11 October 2018
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-AP-10-0037686
Recognitions & Rankings of Riocure Pharmaceuticals
Contact details
Riocure Pharmaceuticals Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is riocurepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD.No.5 – 65 Vivekananda Nagar Old Dairy Farm Arilova, Visakhapatnam, Andhra Pradesh, India – 530040
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Riocure Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Riocure Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Riocure Pharmaceuticals operates one associated brand: Riocure Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| An R&D company manufacturing drugs for various therapeutic areas. | riocurepharma.com |
Business activity
The main business activity of Riocure Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Riocure Pharmaceuticals Private Limited, buy the company report.
Financials of Riocure Pharmaceuticals Private Limited
FY 2025 filings availableRiocure Pharmaceuticals Private Limited reported revenue of ₹1.34 Cr (up 2% YoY) for FY 2024.
Revenue · FY 2024
₹1.34 Cr ▲ 2%
Net profit · FY 2024
₹1.89 Lakh margin 1.4%
EBITDA · FY 2024
₹2.74 Lakh margin 2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 24%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 26%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 2% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Riocure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Riocure Pharmaceuticals Private Limited
Riocure Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Patra Also directs: Riozen Pharmaceutical Private Limited | Director | 28 Jun 2019 | 7 Years 3 Months | Current |
| Sujata Pradhan Subhadarsini | Director | 11 Oct 2018 | 8 Years 0 Months | Current |
Auditor
Riocure Pharmaceuticals Private Limited is audited by SRI DIVYA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRI DIVYA & ASSOCIATES | FY 2022 | 248939 |
Shareholding
The shareholding of Riocure Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Riocure Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹35.43 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jun 2025 | 101148377 | Hdfc Bank Limited | ₹17 Lakh | Open | |
| 09 Mar 2023 | 100728219 | Hdfc Bank Limited | ₹18.43 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Riocure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riocure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Riocure Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAJCR1997B1Z5 | Andhra Pradesh | Active | 08 Nov 2018 |
To see the full GST registrations and return filing status of Riocure Pharmaceuticals Private Limited, buy the company report.
Recent activity
Riocure Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Rajesh Kumar Patra was appointed as Director on 28 Jun 2019.
AGM
Riocure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 17.00 Lakh with Charge ID 101148377 was registered on 10 Jun 2025.
Filing
Riocure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18.43 Lakh with Charge ID 100728219 was registered on 09 Mar 2023.
Appointed
Rajesh Kumar Patra was appointed as Director.
Ceased
Sobana Murphy Arvavinda ceased to be Director.
Appointed
Sujata Pradhan Subhadarsini was appointed as Director.
Incorporation
11 Oct 2018
Riocure Pharmaceuticals Private Limited was registered on 11 Oct 2018 with Roc Vijayawada & aged 8 years 16 days as per MCA records.
Frequently asked questions
Riocure Pharmaceuticals is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 October 2018 (8+ years old) and is registered under CIN U24297AP2018PTC109498.
Riocure Pharmaceuticals has 2 current directors:
- Rajesh Kumar Patra - Director
- Sujata Pradhan Subhadarsini - Director
The latest financial statements of Riocure Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Riocure Pharmaceuticals is 37AAJCR1997B1Z5, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Riocure Pharmaceuticals is U24297AP2018PTC109498. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riocure Pharmaceuticals was incorporated on 11 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Vijayawada.
Rajesh Kumar Patra was appointed as Director on 28 Jun 2019. Sobana Murphy Arvavinda ceased to be Director on 28 Jun 2019. Sujata Pradhan Subhadarsini was appointed as Director on 11 Oct 2018.
Yes, Riocure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-10-0037686).
Riocure Pharmaceuticals can be reached through the website riocurepharma.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The registered office of Riocure Pharmaceuticals is at D.No.5 – 65 Vivekananda Nagar Old Dairy Farm Arilova, Visakhapatnam, Andhra Pradesh, India – 530040.